Income From Continuing Operations - NuVasive Inc (F:NK8) - Alpha Spread
N

NuVasive Inc
F:NK8

Watchlist Manager
NuVasive Inc
F:NK8
Watchlist
Price: 36.8 EUR Market Closed
Market Cap: 1.9B EUR
Have any thoughts about
NuVasive Inc?
Write Note

NuVasive Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NuVasive Inc
Income from Continuing Operations Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
N
NuVasive Inc
F:NK8
Income from Continuing Operations
$28.5m
CAGR 3-Years
N/A
CAGR 5-Years
6%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Income from Continuing Operations
$1.5B
CAGR 3-Years
11%
CAGR 5-Years
3%
CAGR 10-Years
4%
Boston Scientific Corp
NYSE:BSX
Income from Continuing Operations
$1.8B
CAGR 3-Years
46%
CAGR 5-Years
6%
CAGR 10-Years
22%
Stryker Corp
NYSE:SYK
Income from Continuing Operations
$3.4B
CAGR 3-Years
18%
CAGR 5-Years
12%
CAGR 10-Years
18%
Abbott Laboratories
NYSE:ABT
Income from Continuing Operations
$5.6B
CAGR 3-Years
-5%
CAGR 5-Years
14%
CAGR 10-Years
12%
Intuitive Surgical Inc
NASDAQ:ISRG
Income from Continuing Operations
$2.1B
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
16%

See Also

What is NuVasive Inc's Income from Continuing Operations?
Income from Continuing Operations
28.5m USD

Based on the financial report for Jun 30, 2023, NuVasive Inc's Income from Continuing Operations amounts to 28.5m USD.

What is NuVasive Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
6%

Back to Top